Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Registered Rep. August 30, 2011 Amy Burroughs	When Your Client Has Alzheimer's One early sign of the disease is trouble managing money, which puts financial advisors on the front lines.
Investment Advisor May 2007 Kara P. Stapleton	Compassion, Knowledge, and Personalized Service The primary risk factor for Alzheimer's disease is age, and with the majority of financial planners' clientele growing older, it's smart for financial advisors to become familiar with a different side of the financial planning business -- gerontology.
Financial Planning August 1, 2009 Donna Mitchell	Alzheimer's Toll A study surveyed 369 advisors in the U.S. to gauge their understanding of Alzheimer's and their preparedness for dealing with clients who have the disease.
Nurse Practitioner August 2011 Davis et al.	Supportive approaches for Alzheimer Disease Alzheimer disease accounts for almost 80% of all dementia diagnoses. Currently, more than 5 million Americans suffer from this debilitating illness, with the highest prevalence in the oldest age groups.
Registered Rep. June 1, 2005 Gresham & Gresham	Preparing for the End The family dispute and subsequent legal battle in the Schiavo case was ignited by the lack of written advance directives. Clearly, here is a place astute financial advisors can help protect their clients from unnecessary emotional and financial pain.
AskMen.com Jacob Franek	Alzheimer's Disease 101 It's only in the last decade or so that we have truly come to understand the various disorders of the brain that are associated with age and, in most cases, Alzheimer's disease is the prime suspect. Read on for some basic information.
Investment Advisor December 2007 Kara P. Stapleton	Care Givers Smart advisors are offering financial gerontology services to clients and their families, and are getting increased client satisfaction and referrals in return.
The Motley Fool August 17, 2010 Brian Orelli	Forget About This Drug Saving the Company Lilly's Alzheimer's drug fails hard.
Financial Planning September 1, 2013 Samantha Allen	Longer Lives, Higher Costs: Is Your Firm Ready? As boomer clients head into their 70s and beyond, advisors must become geriatric specialists to handle a complex set of new demands.
Chemistry World July 3, 2014 Maria Burke	Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK.
American Journal of Nursing October 2008	How to Try This: Working with Families of Hospitalized Older Adults with Dementia Families provide a considerable amount of informal care and support for older adults living with dementia. And when an older adult with dementia is hospitalized, family caregivers should be seen as important sources of information and included as valuable members of the health care team.
American Family Physician March 15, 2006	Driving and Dementia: What You Should Know A patient hand guide: What is dementia?... How does dementia affect driving?... How do I know if there is a problem?... What can I do if I think someone has a problem?... Where can I get more information?...
Financial Advisor May 2004 David J. Drucker	No Longer An Ancillary Service If your clients are middle-aged or older, learn about old-age care options.
The Motley Fool September 2, 2005 Rich Duprey	An Opportunity Not to Forget Japanese pharmaceutical Eisai targets another segment of the growing Alzheimer's market. Investors, take note.
American Journal of Nursing January 2008 Maslow & Mezey	Recognition of Dementia in Hospitalized Older Adults Recognition of Dementia in Hospitalized Older Adults proposes several approaches that hospital nurses can use to increase recognition of dementia. This article describes the Try This approaches, how to implement them, and how to incorporate them into a hospital's current admission procedures.
Registered Rep. February 13, 2015 Mark Miller	Planning for Alzheimer's Carolyn McClanahan probably pays more attention to her clients' health than the typical financial planner.
Financial Advisor January 2009 David J. Drucker	Dealing With Dementia When a longtime client starts to lose her mental faculties, it's a whole new ball game.
The Motley Fool May 30, 2006 Rich Duprey	NICE Not Playing Nice With Alzheimer's The British health authority proposes limiting availability of Alzheimer's treatments because of cost. What will this mean to drug-makers and their shareholders?
Financial Advisor December 2010 Caren Chesler	Getting Through The Fog Advisors have to make tough but quick decisions when their clients show signs of dementia.
Pharmaceutical Executive October 1, 2011	Patient Advocacy: The Last 30 Years The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Financial Advisor August 2007 Bruce W. Fraser	Drifting Away What do you do when clients show signs of incipient Alzheimer's disease or dementia? As a financial advisor, you're responsible for their assets.
The Motley Fool January 17, 2012 Brian Orelli	You Can Forget About Seeing This Drug Work Medivation and Pfizer's Dimebon fails again.
Salon.com March 1, 2002 Jennifer Foote Sweeney	A cruel choice A woman decides to have a child knowing that she's about to descend into dementia. That's morally indefensible...
American Family Physician June 1, 2002 Jeffrey L. Cummings	Guidelines for Managing Alzheimer's Disease: Part I. Assessment Family physicians play a key role in assessing and managing patients with Alzheimer's disease and in linking the families of these patients to supportive services within the community.
Chemistry World October 8, 2010 Sarah Houlton	U-turn on Alzheimer's drugs in the UK The UK National Institute for Health and Clinical Excellence proposes that those with mild disease will be able to receive them from early next year, on the basis of growing clinical evidence of their effectiveness.
American Family Physician March 1, 2003	Memory Loss Why am I losing my memory?... Where Can I Get More Information?... Memory Problems that Are Not Part of Normal Aging... What about when I know a word but cannot recall it?... How can I tell if my memory problems are serious?... etc.
Registered Rep. July 1, 2005 Gresham & Gresham	Playing Doctor Health care costs are likely to be any retiree's greatest expense. Financial advisors, then, need to address the potential havoc health risks can have on a client's financial plan. The problem is: How to get clients to actually divulge personal medical information.
Investment Advisor June 2010 Olivia Mellan	Longevity, Your Clients, and You The physician and public servant who coined the term "ageism" has some advice for advisors.
American Journal of Nursing January 2010	Life-Support Interventions at the End of Life: Unintended Consequences Nurses need to be knowledgeable life-support interventions at the end of life and able to communicate what they know about those consequences to patients, family members, and others on the health care team, leading to better decision making at this difficult time.
American Family Physician December 15, 2000 James O'Brien	Caring for Caregivers Long-term care given by family members is a central component of our current health care system and, thus, a critical social policy issue...
Salon.com August 29, 2001 Pam Rosenthal	"The Forgetting" by David Shenk A brilliant and quirky new book on Alzheimer's offers food for thought on the unthinkable and a new, deeper understanding of the coming epidemic.
The Motley Fool September 5, 2008 Brian Lawler	Why Pfizer Made an Interesting Blockbuster Bet The pharma giant inked a deal worth potentially more than $725 million with development stage drugmaker Medivation to market Medivation's Alzheimer's disease drug Dimebon.
BusinessWeek July 15, 2010 Lopatto & Matsuyama	The Race for Diagnostic Tests for Alzheimer's GE, Bayer, and Avid are vying to be first to market an early test for Alzheimer's.
American Journal of Nursing October 2008	Wandering in Hospitalized Older Adults: Identifying Risk is the First Step in This Approach to Preventing Wandering in Patients with Dementia. People who have dementia are at risk for wandering away from the safety of the care setting and becoming lost in the community. Here are three critical elements of prevention and action.
American Family Physician March 1, 2006	Dementia with Lewy Bodies A patient and care-giver's guide: What is dementia with Lewy bodies?... How can my doctor tell if I have this type of dementia?... How is dementia with Lewy bodies treated?... etc.
American Family Physician February 15, 2006	Behavior Problems in a Family Member with Dementia: What You Should Know An informative hand-out on the condition: What kinds of problems do people with dementia have?... Will these problems get worse?... Can my doctor tell if some other illness is causing the problems?... etc.
The Motley Fool November 9, 2010 Brian Orelli	Forget R&D; Buy Your Way Into Diagnostics Eli Lilly is expanding its diagnostics business by picking up privately held Avid Radiopharmaceuticals.
Commercial Investment Real Estate Mar/Apr 2006 John Cobb	Seniors Housing Blossoms The outlook is rosy for this perennial investment: long-term care facilities and seniors housing.
Chemistry World August 9, 2012	Bapineuzunab dropped Pfizer and Johnson and Johnson have announced that they are ending development of the intravenous Alzheimer's drug bapineuzumab after it failed in two clinical trials.
American Journal of Nursing April 2011	Strategies for Feeding Patients with Dementia An overview of the difficulties associated with feeding those with dementia and suggestions for caregivers to help overcome these challenges.
Chemistry World October 14, 2009 Phil Taylor	Tracing amyloid in Alzheimer's A diagnostic compound that allows researchers to look into the brains of Alzheimer's patients will be used for the first time to gauge the effects of an experimental therapy for the disease.
American Family Physician June 15, 2002 Jeffrey L. Cummings	Guidelines for Managing Alzheimer's Disease: Part II. Treatment Once the clinical diagnosis of Alzheimer's disease has been made, a treatment plan must be developed. Patient symptoms and care needs change as Alzheimer's disease progresses.
The Motley Fool January 19, 2011 Brian Orelli	High Stakes at Tomorrow's FDA Panel Meeting It's more than just Eli Lilly on the line.
American Family Physician October 1, 2005 Crane, Wittink & Doukas	Respecting End-of-Life Treatment Preferences Research suggests that families are the best sources of patients' values and preferences, and that patients will more likely choose a loved one to make future decisions for them than someone who might best articulate their wishes.
American Family Physician October 1, 2000	Advance Directives and Do-Not-Resuscitate Orders What are advance directives?... What is a living will?... What is a durable power of attorney for health care?... Are living wills and DPAs legal in every state?... What is a do-not-resuscitate order?... Who should have an advance directive?... How can I write one?...
American Family Physician April 1, 2006 Neef & Walling	Dementia with Lewy Bodies: An Emerging Disease Dementia with Lewy bodies appears to be the second most common form of dementia, accounting for about one in five cases. The condition is characterized by dementia accompanied by delirium, visual hallucinations, and parkinsonism.
American Family Physician December 15, 2000	When You Are the Caregiver You're a caregiver if you give basic care to a person who has a chronic medical condition. How can I tell if caregiving is putting too much stress on me?... Why is caring for someone with dementia (Alzheimer's disease) so hard?... etc.
The Motley Fool October 13, 2006 Rich Duprey	NICE Is Just Dumb The British health agency prohibits the use of certain Alzheimer's treatments because of cost.
The Motley Fool February 8, 2005 Charly Travers	Investing in a Cure Drugs in the pipeline offer potential breakthroughs for Alzheimer's disease. Instead of investing in small biotechs that have a lot riding on a single Alzheimer's program, the best way to invest in the field is through a diversified company
Chemistry World November 2, 2006 Michael Gross	Alzheimer's Century Researchers worldwide are commemorating the centenary of Alois Alzheimer's first description of the dementia named after him.